Lyka Labs Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
LYKALABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The promoters of Lyka Labs Limited — Ipca Laboratories Ltd. and members of the Godha family (Pranay, Neetu, Usha, Bhawna, and Premchand Godha) — have submitted an annual declaration to NSE and BSE under Regulation 31(4) of SEBI's Takeover Regulations. The declaration confirms that the promoters and persons acting in concert have not created any encumbrance (pledge, lien, or charge) on their equity shares in Lyka Labs for the financial year ended 31st March 2025. This is a routine yearly compliance filing required of all promoter groups of listed companies.
This is a neutral, routine compliance filing and should not affect the stock price. It simply reassures shareholders that the promoters have not pledged or encumbered their holdings during the year, which is mildly positive for shareholding stability.